Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Tachykinin antagonists claimed by HMR for asthma, cough, bronchitis and pain

Feb. 3, 1999

Dihydropyridines from Pfizer show excellent bradykinin-antagonist effects

Feb. 2, 1999

First market introduction for new asthma treatment --Seretide Diskus

Feb. 1, 1999

Grant will help Copernicus develop novel targeted CF gene therapy

Feb. 1, 1999

Phthalimide derivatives from JT selectively inhibit IL-5 and IgE production

Feb. 1, 1999

Novel class of PAF antagonists presented by Searle

Feb. 1, 1999

Pharmadigm enters agreement with Mipharm for PB-005

Jan. 26, 1999

Novel antiallergic agents from Nissan act as both substance P and histamine antagonists

Jan. 26, 1999

Meta-analysis supports first-line use of inhaled corticosteroids for allergic rhinitis

Jan. 21, 1999

IntraBiotics initiates phase I clinical trial of protegrin IB-367 aerosol

Jan. 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...